Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) — Cash Flow Quality Index
Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) has a Cash Flow Quality Index of -1.69x as of March 2026. Operating cash flow of ₫-135.66 Billion is below net income of ₫80.30 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore DBD cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Binh Dinh Pharmaceutical and Medical Equipment JSC Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Binh Dinh Pharmaceutical and Medical Equipment JSC across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how aggressively does Binh Dinh Pharmaceutical and Medical Equ reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Binh Dinh Pharmaceutical and Medical Equipment JSC (2019–2025)
Year-by-year earnings quality comparison for Binh Dinh Pharmaceutical and Medical Equipment JSC. For live market cap and the full company financial profile, see Binh Dinh Pharmaceutical and Medical Equ stock valuation.
| Year | Quality Index | Operating CF (VND) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.11x | ₫615.19 Billion | ₫291.94 Billion | ▲ +119.0% |
| 2024 | 0.96x | ₫264.73 Billion | ₫275.18 Billion | ▼ -11.9% |
| 2023 | 1.09x | ₫293.99 Billion | ₫269.28 Billion | ▲ +61.1% |
| 2022 | 0.68x | ₫165.01 Billion | ₫243.56 Billion | ▲ +5.9% |
| 2021 | 0.64x | ₫117.57 Billion | ₫183.79 Billion | ▼ -52.6% |
| 2020 | 1.35x | ₫212.91 Billion | ₫157.86 Billion | ▲ +18612.7% |
| 2019 | -0.01x | ₫-1.04 Billion | ₫142.23 Billion | — |